Publications
5539 Results
- Journal / Conference
- Gynecologic Oncology 95:506-512
- Year
- 2004
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-9324
Phase II trial of vinorelbine for relapsed ovarian cancer. A Southwest Oncology Group Study
- Journal / Conference
- Proc of AACR Frontiers in Cancer Prevention Research, Oct 16-20:131 (#884)
- Year
- 2004
- Research Committee(s)
- Prevention and Epidemiology
- Study Number(s)
- S0000
Participant's perception of recruitment and retention in the selenium and vitamin E cancer prevention trial
- Journal / Conference
- Blood 104(11): #2288
- Year
- 2004
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0108
Expression of VEGF, VEGF receptors, and other angiogenic markers in relapsed aggressive non-Hodgkin's lymphoma: correlative studies from the SWOG S0108 trial
- Journal / Conference
- New England Journal of Medicine 350(19):1937-1944
- Year
- 2004
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-9515 (RTOG-9501)
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
- Journal / Conference
- Proc of the American Society of Clinical Oncology 23:663 (#7202)
- Year
- 2004
- Research Committee(s)
- Lung
- Study Number(s)
- S0119
SWOG S0119: a phase II study of gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer (SCLC)
- Journal / Conference
- Proc of the American Society of Clinical Oncology 23:649 (#7146)
- Year
- 2004
- Research Committee(s)
- Lung
- Study Number(s)
- S0003
Hypoxia-related markers in the plasma of patients with advanced non-small cell lung cancer (NSCLC) and survival from chemotherapy: Southwest Oncology Group (SWOG) S0003
- Journal / Conference
- Proc of the American Society of Clinical Oncology 23:250 (#3521)
- Year
- 2004
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- N9741
Insulin-like growth factor-I (IGF-1), IGF binding protein-3 (IGFBP-3), and outcome in metastatic colorectal cancer (CRC): Results from Intergroup Trial N9741
- Journal / Conference
- Proc of the American Society of Clinical Oncology 23:275 (#3621)
- Year
- 2004
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- N9741
N9741: FOLFOX (oxaliplatin (oxal)/ 5-fluorouracil (5-FU)/ leucovorin (LV) or reduced dose R-IFL (CPT-11 + 5-FU/LV) in advanced colorectal cancer (CRC): Final efficacy data from an intergroup study
- Journal / Conference
- Blood 104(11): #127
- Year
- 2004
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E4494
Rituximab-CHOP versus CHOP with or without maintenance rituximab in patients 60 years of age or older with diffuse large B-cell lymphoma (DLBCL): an update
- Journal / Conference
- Blood 104(11): #352
- Year
- 2004
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-9438